Related Experiment Videos
Causes and consequences of nonpersistence with heart failure medication
Mary Mockler1, Christina O'Loughlin, Niamh Murphy
1Heart Failure Unit, St Vincent's University Hospital, Elm Park, Dublin, Ireland.
The American Journal of Cardiology
|March 10, 2009
Summary
Nonpersistence with heart failure (HF) therapy is common and often lacks medical justification. This nonpersistence significantly increases the risk of all-cause and cardiovascular hospital readmissions for HF patients.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Therapy persistence is a key metric in managing chronic conditions like heart failure (HF).
- Nonpersistence with disease-modifying therapy in HF is linked to increased mortality.
- Identifying nonpersistence is more objective than compliance in clinical practice.
Purpose of the Study:
- To investigate the prevalence, reasons, and clinical consequences of nonpersistence with disease-modifying therapy in systolic HF patients.
- To analyze the impact of nonpersistence on hospital readmissions within a HF disease management program.
Main Methods:
- Retrospective cohort study of 183 patients with systolic heart failure.
- Analysis of nonpersistence occurrences, reasons for discontinuation, and subsequent hospitalizations.
- Statistical analysis including hazard ratios to determine predictors of readmission.
Main Results:
- 29% of patients experienced 74 episodes of nonpersistence with HF therapy.
- 50% of nonpersistence episodes lacked a medical reason; 30% were due to adverse reactions.
- Nonpersistence significantly predicted all-cause (HR 3.20) and cardiovascular (HR 4.45) readmissions.
Conclusions:
- Nonpersistence with heart failure therapy is frequent and frequently medically unjustified.
- Nonpersistence is a significant risk factor for hospital readmission in HF patients.
- Interventions to improve therapy persistence are crucial for better HF management and outcomes.
Related Concept Videos
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:30Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.